HMOX2
Basic information
Region (hg38): 16:4474690-4510347
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HMOX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 2 | 1 |
Variants in HMOX2
This is a list of pathogenic ClinVar variants found in the HMOX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-4505561-G-A | not specified | Uncertain significance (Jun 28, 2022) | ||
16-4506947-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
16-4506948-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
16-4507002-A-G | not specified | Uncertain significance (Dec 21, 2021) | ||
16-4507747-C-G | not specified | Uncertain significance (Dec 26, 2023) | ||
16-4507817-G-A | Benign (Jun 10, 2018) | |||
16-4507831-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
16-4507894-A-T | not specified | Uncertain significance (May 31, 2023) | ||
16-4507903-A-G | not specified | Likely benign (Jan 04, 2022) | ||
16-4507974-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
16-4507986-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
16-4507993-C-T | not specified | Uncertain significance (May 23, 2023) | ||
16-4508015-G-C | not specified | Uncertain significance (Jan 26, 2023) | ||
16-4508194-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
16-4509412-A-T | not specified | Uncertain significance (Apr 01, 2024) | ||
16-4509414-A-G | not specified | Uncertain significance (Jan 24, 2024) | ||
16-4509418-A-C | not specified | Uncertain significance (Sep 21, 2023) | ||
16-4509433-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
16-4509511-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
16-4509526-G-A | not specified | Likely benign (Dec 06, 2023) | ||
16-4509533-A-G | not specified | Uncertain significance (Aug 19, 2023) | ||
16-4509650-G-C | not specified | Uncertain significance (May 27, 2022) | ||
16-4509749-A-G | not specified | Uncertain significance (May 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HMOX2 | protein_coding | protein_coding | ENST00000570646 | 5 | 35658 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000262 | 0.936 | 125560 | 2 | 185 | 125747 | 0.000744 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.113 | 182 | 186 | 0.977 | 0.0000107 | 2081 |
Missense in Polyphen | 43 | 53.506 | 0.80364 | 620 | ||
Synonymous | -0.190 | 78 | 75.9 | 1.03 | 0.00000466 | 593 |
Loss of Function | 1.67 | 8 | 14.9 | 0.535 | 8.02e-7 | 173 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00154 | 0.00144 |
Ashkenazi Jewish | 0.0131 | 0.0130 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000101 | 0.0000980 |
Other | 0.000979 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed. Heme oxygenase 2 could be implicated in the production of carbon monoxide in brain where it could act as a neurotransmitter.;
- Pathway
- Porphyrin and chlorophyll metabolism - Homo sapiens (human);Mineral absorption - Homo sapiens (human);Neutrophil degranulation;oxidative stress induced gene expression via nrf2;heme degradation;Heme degradation;Metabolism of porphyrins;Innate Immune System;Immune System;Metabolism;Transport of small molecules;Iron uptake and transport
(Consensus)
Recessive Scores
- pRec
- 0.626
Intolerance Scores
- loftool
- 0.879
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.45
Haploinsufficiency Scores
- pHI
- 0.0905
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hmox2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- response to hypoxia;heme oxidation;cellular iron ion homeostasis;response to oxidative stress;heme catabolic process;neutrophil degranulation;iron ion homeostasis
- Cellular component
- endoplasmic reticulum membrane;plasma membrane;membrane;specific granule membrane
- Molecular function
- heme oxygenase (decyclizing) activity;protein binding;heme binding;metal ion binding